Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy

Radiology. 1995 Feb;194(2):545-9. doi: 10.1148/radiology.194.2.7529936.

Abstract

Purpose: To characterize the racial differences in prognostic factors and treatment outcome for patients undergoing radiation therapy for carcinoma of the prostate.

Materials and methods: From January 1975 through December 1989, 489 white and 157 black men with carcinoma of the prostate underwent irradiation. Factors analyzed were patient age, tumor stage and grade, prostate-specific antigen (PSA) levels, and disease-control and survival rates.

Results: More black patients than white patients were found to have poorly differentiated tumors. Black patients had higher PSA levels before and after treatment, resulting in a higher distant failure rate and poorer overall, cause-specific, and disease-free survival rates.

Conclusion: Black men have more aggressive prostatic tumors, a higher rate of metastasis, and a poorer survival rate than do white men.

MeSH terms

  • Aged
  • Black People*
  • Disease-Free Survival
  • Humans
  • Male
  • Prognosis
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Survival Rate
  • White People*

Substances

  • Prostate-Specific Antigen